Supplementary Figure 1 from Concordance between Tumor Tissue and Plasma DNA Genotyping in the NCI-MATCH Trial (EAY131) | Synapse
October 17, 2025Open Access
Supplementary Figure 1 from Concordance between Tumor Tissue and Plasma DNA Genotyping in the NCI-MATCH Trial (EAY131)
Key Points
Cell-free DNA yield was measured in ng per ml plasma, highlighting significant variations across diagnostic groups.
Patients showed differing levels of cell-free DNA yield, with specific findings relevant to tumor tissue genotyping.
Assessment involved categorizing plasma DNA yield according to diagnostic classifications, contributing to better understanding of DNA analysis.
Findings suggest that plasma DNA genotyping could complement tumor tissue testing for improved diagnostic accuracy.
Abstract
Supplementary Figure 1. Cell-free DNA yield in included patients. Yield is presented in ng per ml plasma and categorized according to the diagnostic group.